O'REILLY v. Transworld Healthcare, Inc.

745 A.2d 902, 1999 Del. Ch. LEXIS 185, 1999 WL 693166
CourtCourt of Chancery of Delaware
DecidedAugust 20, 1999
DocketC.A. 16507
StatusPublished
Cited by69 cases

This text of 745 A.2d 902 (O'REILLY v. Transworld Healthcare, Inc.) is published on Counsel Stack Legal Research, covering Court of Chancery of Delaware primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
O'REILLY v. Transworld Healthcare, Inc., 745 A.2d 902, 1999 Del. Ch. LEXIS 185, 1999 WL 693166 (Del. Ct. App. 1999).

Opinion

OPINION

STEELE, Vice Chancellor.

Defendants Transworld Healthcare, Inc. (“Transworld”) and the former directors of Health Management Inc. (“HMI”) move to dismiss pursuant to Court of Chancery Rule 12(b)(6) this individual and stockholder class action against them, which challenges the fairness of HMI’s merger' with a subsidiary of Transworld. HMI’s directors approved a merger between HMI and Transworld’s wholly-owned subsidiary at $2 per share, but agreed to reduce the merger consideration to $1.00 per share, and then to $.30 per share after two revelations of accounting errors in HMI’s financial statements. During HMI and Transworld’s negotiations, a second bidder, Counsel Corp., opened up acquisition talks with HMI. HMI did not pursue merger negotiations with Counsel Corp. After HMI’s stockholders approved the merger with Transworld’s subsidiary, but before the merger was consummated, Transworld agreed to sell HMI’s assets to Counsel Corp. Following the merger, Transworld sold HMI’s assets to Counsel Corp. at a profit.

Plaintiff O’Reilly alleges that Trans-world leveraged its 49% ownership of HMI’s outstanding voting stock, its option to purchase 2% of HMI’s stock, and its $49 million in HMI debt holdings at the time of the renegotiations to squeeze unfair concessions from a financially ailing HMI and to prevent HMI from negotiating with Counsel Corp. so that Transworld could resell HMI’s assets to Counsel Corp. at a higher price. She alleges that the Defendants breached their duty of disclosure in *909 a Proxy Statement issued in connection with the merger and that the merger process and price were unfair.

Because O’Reilly asserts well-pleaded allegations that: (i) Transworld was an HMI controlling stockholder with concomitant fiduciary status; (ii) the HMI directors’ conduct falls within the exceptions of HMI’s certificate of incorporation’s exculpation provision tracking the language of 8 Del.C. § 102(b)(7); (iii) the merger’s Proxy Statement contained false statements regarding Transworld’s purpose for engaging in the merger and the “arms-length” nature of the merger negotiations; and (iv) the merger process and price were unfair, I deny in part Defendants’ motion to dismiss.

Because O’Reilly fails to set forth well pleaded allegations in support of certain other claims against Defendants for breach of the fiduciary duty of disclosure, I grant in part Defendants’ motion.

I. Background 1

A.The Parties

Defendant HMI, a Delaware corporation, provided pharmaceutical management to patients with long-term medical conditions and similar health-related services. Defendants Nicol, Dimitriadis, Triche, and Weinberg were HMI’s four directors. On October 1, 1997, HMI merged with a wholly owned subsidiary of Defendant Trans-world (the “Merger”). Transworld is a New York corporation that is a regional provider of a broad range of healthcare services and products. Plaintiff O’Reilly owned 2,600 shares of HMI stock at the time of the Merger.

B. The Events Leading up to Merger Negotiations

In the Spring of 1996, HMI’s board of directors learned that HMI’s financial statements going back to 1994 were inaccurate. HMI restated its financials, which revealed significant deterioration in HMI’s financial condition. To account for the restated finances, HMI recorded special charges in 1995 and 1996 including reductions in working capital, retained earnings and stockholders’ equity. For 1996, HMI reported a net operating loss of over $8 million, reflecting, among other things, a $2.8 million write off for medical device inventory, a $3.6 million charge for reorga-nizational costs, and an $8.4 million reserve to allow for an increase in doubtful accounts. As a result, HMI defaulted on its loan agreements. The board responded to this crisis by hiring National Westminster Bank Pic (“NatWest”) to assist HMI in evaluating a number of strategic and financial options. After rejecting the possibility of a private security placement, HMI’s board began looking for someone willing to acquire the ailing company.

C. HMI’s Negotiations And Agreements with Transworld

In October 1996, HMI met with Trans-world. On November 13, 1996, HMI and Transworld entered into a stock purchase agreement (the “Stock Purchase Agreement”) and a merger agreement (the “Merger Agreement”). Pursuant to the Stock Purchase Agreement, Transworld agreed to acquire 49% of HMI’s outstanding voting stock and Transworld acquired an option to purchase an additional 2% of HMI’s outstanding voting stock. Trans-world paid the following consideration for the HMI stock under the Stock Purchase *910 Agreement: (i) $1 per share; (ii) Trans-world’s agreement to execute the Merger Agreement; (iii) Transworld’s purchase of the rights of HMI’s senior lenders under HMI’s credit agreements; (iv) Trans-world’s extension of the expiration of a forbearance agreement which HMI had entered into with its senior lenders; (v) Transworld’s agreement to lend additional amounts under HMI’s revolving credit facility, subject to certain conditions; and (vi) Transworld’s cancellation of warrants held by the lenders that Transworld was effectively replacing. Pursuant to the Merger Agreement, Transworld agreed to acquire HMI’s publicly-traded stock for $2.00 per share. HMI’s board obtained an opinion from NatWest which stated that from a financial perspective the $2.00 per share Merger price was fair to the non-Transworld HMI’s stockholders.

As contemplated by the Stock Purchase Agreement, Transworld: (i) acquired HMI’s bank debt; (ii) extended the termination date of the pre-existing forbearance agreement HMI had entered with its senior lenders, which was to terminate on November 15, 1996, to December 12, 1996; and (iii) promised to lend up to an additional $3 million to HMI under HMI’s revolving line of credit. In November and December 1996, Transworld’s principal stockholder, Hyperion Partners II L.P., acquired approximately $18 million in additional debt which HMI owed to various entities. As a result, Transworld and one of its affiliates owned virtually all of HMI’s debt.

In January of 1997, Transworld informed HMI that because of HMI’s “adverse business results,” Transworld would exercise its right to decline to consummate its agreement to purchase 49% of HMI’s stock and the Merger Agreement, unless the Merger price were renegotiated to $1.50 per share. The HMI board unanimously agreed, and on January 13, 1997, Transworld and HMI signed an amended merger agreement reflecting, among other things, the reduced Merger price. The HMI board received another “fairness opinion” from NatWest declaring the $1.50 per share Merger price to be fair. Also on January 13, 1997, Transworld consummated the purchase of 49% of HMI’s outstanding voting stock, as contemplated in the Stock Purchase Agreement.

After reviewing Transworld’s due diligence findings, on January 14, 1997, HMI hired BDO Seidman, LLP (“BDO Seid-man”) to review HMI’s accounts receivable. BDO Seidman discovered that HMI’s financial statements for the first three-quarters of fiscal 1997 were inaccurate. Written analyses of BDO Seidman’s findings were distributed to the HMI board and Transworld. After reviewing the analyses, Transworld concluded that HMI’s equity had no value.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Paul Witmer v. Armistice Capital, LLC
Court of Chancery of Delaware, 2025
Morano v. Redfin Corporation
W.D. Washington, 2025
Ezell v. Dinges
Fifth Circuit, 2025
Richard Frank v. Michael Mullen
Court of Chancery of Delaware, 2025
Hideaki Honma v. Mark Schacknies
Court of Chancery of Delaware, 2024
Michael Conte v. Robert Greenberg
Court of Chancery of Delaware, 2024
Richard J. Tornetta v. Elon Musk
Court of Chancery of Delaware, 2024
In Re Mindbody, Inc. Stockholder Litigation
Court of Chancery of Delaware, 2023
Richard Delman v. GigAquisitions3, LLC
Court of Chancery of Delaware, 2023
In Re: Mindbody, Inc. Stockholders Litigation
Court of Chancery of Delaware, 2020
Nuvasive, Inc. v. Patrick Miles
Court of Chancery of Delaware, 2020
Gallagher Industries, LLC v. William M. Addy
Court of Chancery of Delaware, 2020
Robert A. Davidow v. LRN Corporation
Court of Chancery of Delaware, 2020
Duygun v. Allen
Superior Court of Delaware, 2019

Cite This Page — Counsel Stack

Bluebook (online)
745 A.2d 902, 1999 Del. Ch. LEXIS 185, 1999 WL 693166, Counsel Stack Legal Research, https://law.counselstack.com/opinion/oreilly-v-transworld-healthcare-inc-delch-1999.